This progress is hugely important for all investors / potential investors to get educated on then better appreciate. We are all more focused on our Bucillamine for the foreseeable future however, this pioneering progress by Revive within the Psychedelic space represents a first-mover advantage and is an extra reason to invest in and stick with this stock. Having a former FDA pro on the Revive team is immensely valuable.
News 
Market Data 
Discover 
